Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

dydrogesterone

A synthetic, orally active progestin that may be useful in the treatment of disorders attributed to progesterone deficiency. Upon administration, dydrogesterone binds to progesterone receptors with high affinity and helps regulate the healthy growth and normal shedding of the uterine lining. Dydrogesterone appears to have no affinity for androgenic, estrogenic, glucocorticoid or mineralocorticoid receptors.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	didrogesterone hydrogestrone isopregnenone
US brand name:	Duphaston
Chemical structure:	(9-beta,10-alpha)-pregna-4,6-diene-3,20-dione retro-6-dehydroprogesterone
NSC code:	92336

dydrogesterone

Search NCI's Drug Dictionary